Amgen Investor

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illness and diseases.
Technology: CAR-T, Space Medicine
Industry: Longevity Industry 2022
Headquarters: Thousand Oaks, California, United States
Founded Date: 1980-01-01
Employees Number: 10001+
Funding Status: IPO
Investor Type: Undisclosed
Investment Stage: N/A
Number Of Exits: 3
Acquisitions Number: 24
Total Funding: 40000000
Estimated Revenue: $10B+

Visit Website
Register and Claim Ownership
Suggested by Amgen